Cambridge Investment Research Advisors’s Calvert Ultra-Short Investment Grade ETF CVSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Sell
8,987
-8,499
-49% -$431K ﹤0.01% 3054
2026
Q1
$885K Buy
17,486
+316
+2% +$16K ﹤0.01% 2281
2025
Q4
$871K Buy
17,170
+1,030
+6% +$52.3K ﹤0.01% 2208
2025
Q3
$819K Buy
16,140
+244
+2% +$12.4K ﹤0.01% 2209
2025
Q2
$805K Buy
15,896
+8,326
+110% +$422K ﹤0.01% 2130
2025
Q1
$383K Buy
7,570
+307
+4% +$15.6K ﹤0.01% 2669
2024
Q4
$368K Buy
7,263
+2,040
+39% +$104K ﹤0.01% 2669
2024
Q3
$265K Buy
+5,223
New +$265K ﹤0.01% 2918

Other funds holding CVSB

Cambridge Investment Research Advisors's CVSB Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Calvert Ultra-Short Investment Grade ETF (CVSB) stake by 49% in Q2 2026, selling an estimated $431K and leaving 8,987 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #3054.

Cambridge Investment Research Advisors first reported a position in CVSB in Q3 2024 and has held it in 8 quarters since. The position peaked at $885K in Q1 2026. 18 funds tracked by Wall St. Rank hold CVSB as of Q2 2026.

  • Cambridge Investment Research Advisors held 8,987 shares of Calvert Ultra-Short Investment Grade ETF worth $455K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 8,499 Calvert Ultra-Short Investment Grade ETF shares in Q2 2026, an estimated $431K.
  • Calvert Ultra-Short Investment Grade ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3054 holding.
  • Cambridge Investment Research Advisors first reported a position in Calvert Ultra-Short Investment Grade ETF in Q3 2024 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's Calvert Ultra-Short Investment Grade ETF position peaked at $885K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Calvert Ultra-Short Investment Grade ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.